Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

THERAPY trial to evaluate benefits of catheter-based intervention for acute ischemic stroke

During the opening session of the SNIS Annual Meeting, J Mocco, MD, MS, Assistant Professor of Neurosurgery at The University of Florida in Gainesville, FL, announced the IDE approval and initiation of THERAPY, an industry-sponsored randomized controlled trial designed to prove the clinical benefit of interventional treatment of acute ischemic stroke.

26 Jul 2011

New larger lumen catheter for clot removal in ischemic stroke patients

Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients and distal access solutions, today announced the launch of the DAC 070 Catheter.

26 Jul 2011

Enrollment complete in Sapheon's clinical study of saphenous vein reflux disease treatment

Sapheon Inc. announced successful enrollment in a 30-patient, prospective, single-arm clinical study of the Sapheon Closure System — a single-use, minimally invasive approach to the treatment of saphenous vein reflux disease.

22 Jul 2011

Localized one-time gene therapy might effectively protect against atherosclerosis

A one-dose method for delivering gene therapy into an arterial wall effectively protects the artery from developing atherosclerosis despite ongoing high blood cholesterol.

21 Jul 2011

US FDA advisory panel votes yes for Edwards heart valve

An U.S. Food and Drug Administration advisory panel met Wednesday to discuss the approval of Edwards Lifesciences Corp's heart valve for patients deemed too sick to have open-heart surgery. The panel voted 9-0 with one abstention in favor of valve.

20 Jul 2011

Series of articles explore recent evidence-based vascular medicine

As the population ages and obesity and diabetes increase, more people suffer from noncardiac vascular diseases. In the July/August issue of Progress in Cardiovascular Diseases, published by Elsevier, a series of articles from recognized experts on key topics in vascular disease and endovascular medicine provide an insightful compendium of the evidence available to help improve the care of this complex patient population.

20 Jul 2011

Main Street completes $6.5 million new portfolio investment

Main Street Capital Corporation announced today that it has completed a new portfolio investment totaling $6.5 million.

19 Jul 2011

Texas Children's Hospital uses new surgical approach for treating epilepsy

Texas Children's Hospital is the first hospital in the world to use real-time MRI-guided thermal imaging and laser technology to destroy lesions in the brain that cause epilepsy and uncontrollable seizures.

19 Jul 2011

Coronary CTA non-invasive and safe for children

Coronary computed tomography angiography (CTA) has excellent image quality and diagnostic confidence for the entire spectrum of pediatric patients, with significant reduction of risk with recent technological advancements, according to a study to be presented at the Sixth Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) in Denver, July 14-17.

18 Jul 2011

Novel combined technique for treating neoplastic meningitis, hydrocephalus

Approximately five to ten percent of patients with primary or metastatic cancer suffer from devastating neurological complications such as headaches, seizures, confusion, difficulty swallowing and visual disturbances. These deficits are caused by a life-threatening form of brain invasion from cancer called neoplastic meningitis.

15 Jul 2011

NeoStem to acquire Amorcyte

NeoStem, Inc., an international biopharmaceutical company, announced the signing of a definitive merger agreement whereby NeoStem will acquire Amorcyte, Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease.

15 Jul 2011

New low-energy method for terminating cardiac fibrillation

An international team of scientists from the Max-Planck-Institute for Dynamics and Self-Organization, Cornell University the Ecole Normale Supérieure de Lyon, the University Medicine Göttingen, the Rochester Institute of Technology, and the Institut Non-Linéaire de Nice have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart.

14 Jul 2011

New less painful technique to end life-threatening heart fibrillations

Cornell scientists, in collaboration with physicists and physician-scientists in Germany, France and Rochester, N.Y., have developed a new - and much less painful and potentially damaging - method to end life-threatening heart fibrillations.

14 Jul 2011

DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the company has made landmark progress in reducing "Day 90+" patient central venous catheter (CVC) rates, further cementing its position as the industry leader among large dialysis organizations in catheter reductions through the placement of permanent accesses.

14 Jul 2011

InfraReDx commences LipiScan IVUS System Phase 2 trial against heart attack

InfraReDx, Inc., a medical device company providing intelligent cardiovascular diagnostic imaging technologies, today announced enrollment of the first patient in its Phase 2 clinical trial, CANARY (Coronary Assessment by Near-infrared (NIR) of Atherosclerotic Rupture-prone Yellow).

13 Jul 2011

Heart experts begin to test new device for treatment of blocked aortic valves

Heart experts at Johns Hopkins have begun testing a new device designed to replace blocked aortic valves in patients for whom traditional open-heart surgery is considered too risky, such as elderly patients and those with other serious medical conditions.

13 Jul 2011

Sequana Medical's ALFApump System for liver cirrhosis receives CE Mark approval

Sequana Medical announced today that it has received CE Mark approval for the commercial sale of its ALFApump System.

13 Jul 2011

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.

From Medtronic 12 Jul 2011

RyMed's InVision-Plus Intraluminal Protection System effective against catheter-related bloodstream infections

Denise Macklin, BSN, RNC, representing the research team of Dr. Cynthia C. Chernecky Ph.D., RN, AOCN, FAAN, Dr. Jennifer Waller, Ph.D., both from Georgia Health Sciences University; and Dr. William Jarvis M.D., Jason & Jarvis Associates, exhibited a poster at the recent APIC 2011 (Association for Professionals in Infection Control and Epidemiology) conference in Baltimore, titled "Clinical Comparisons of Split Septum, Positive and Negative Mechanical Valve Intravenous Connectors to an Intraluminal Protection Connector on Infection Rates."

11 Jul 2011

Fibrin key to protection during gram-negative sepsis

New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's laboratory. It shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice.

11 Jul 2011